Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report

[1]  D. Keskin,et al.  Possible role of natural killer cells in pemphigus vulgaris − preliminary observations , 2008, Clinical and experimental immunology.

[2]  D. Keskin,et al.  Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy. , 2008, Cytokine.

[3]  M. Palmer,et al.  Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle. , 2007, Veterinary immunology and immunopathology.

[4]  T. Hawn,et al.  Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? , 2007, Immunological reviews.

[5]  Francesco Bistoni,et al.  IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance , 2007, European journal of immunology.

[6]  J. Keane,et al.  T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. , 2007, Immunity.

[7]  T. Mori,et al.  Waning of the specific interferon-gamma response after years of tuberculosis infection. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  S. Narayanan,et al.  Mycobacterium tuberculosis H37Rv induces monocytic release of interleukin-6 via activation of mitogen-activated protein kinases: inhibition by N-acetyl-L-cysteine. , 2007, FEMS immunology and medical microbiology.

[9]  R. Romieu-Mourez,et al.  Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density1 , 2007, The Journal of Immunology.

[10]  T. Laskay,et al.  Interferon‐gamma‐dependent mechanisms of mycobacteria‐induced pulmonary immunopathology: the role of angiostasis and CXCR3‐targeted chemokines for granuloma necrosis , 2007, The Journal of pathology.

[11]  H. Bibi,et al.  Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. , 2007, The Israel Medical Association journal : IMAJ.

[12]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[13]  J. Chan,et al.  B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis1 , 2007, The Journal of Immunology.

[14]  J. Flynn,et al.  Tumor necrosis factor and tuberculosis. , 2007, The journal of investigative dermatology. Symposium proceedings.

[15]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[16]  S. Nakae,et al.  IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guérin Infection1 , 2007, The Journal of Immunology.

[17]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[18]  J. Flynn,et al.  IL-17 Production Is Dominated by γδ T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[19]  J. Keane,et al.  Gene expression profiling of peripheral blood mononuclear cells (PBMC) from Mycobacterium bovis infected cattle after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD). , 2006, Veterinary immunology and immunopathology.

[20]  J. Son,et al.  The Mycobacterial 38-Kilodalton Glycolipoprotein Antigen Activates the Mitogen-Activated Protein Kinase Pathway and Release of Proinflammatory Cytokines through Toll-Like Receptors 2 and 4 in Human Monocytes , 2006, Infection and Immunity.

[21]  P. Adnet,et al.  Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. , 2006, Vaccine.

[22]  M. Urata,et al.  Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing. , 2005, The Journal of investigative dermatology.

[23]  D. Keskin,et al.  Copolymer effects on microglia and T cells in the central nervous system of humanized mice , 2005, European journal of immunology.

[24]  B. Robertson,et al.  Mycobacterial Mutants with Defective Control of Phagosomal Acidification , 2005, PLoS pathogens.

[25]  Shi-chuan Chang,et al.  Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. , 2005, Clinical Immunology.

[26]  V. Deretic,et al.  Endosomal membrane traffic: convergence point targeted by Mycobacterium tuberculosis and HIV , 2004, Cellular microbiology.

[27]  Vojo Deretic,et al.  Cell biology of mycobacterium tuberculosis phagosome. , 2004, Annual review of cell and developmental biology.

[28]  D. Keskin,et al.  Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Brosnan,et al.  Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Bozkurt,et al.  Change in Serum Concentrations of Interleukin-2 and Interferon-γ during Treatment of Tuberculosis , 2004, The Journal of international medical research.

[31]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[32]  M. Morosini,et al.  The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[33]  T. Mustafa,et al.  In Situ Expression of CD40, CD40L (CD154), IL‐12, TNF‐α, IFN‐γ and TGF‐β1 in Murine Lungs during Slowly Progressive Primary Tuberculosis , 2003, Scandinavian journal of immunology.

[34]  R. Ransohoff.  The chemokine system in neuroinflammation: an update. , 2002, The Journal of infectious diseases.

[35]  C. Heldin,et al.  Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. , 2002, American journal of respiratory cell and molecular biology.

[36]  E. Chan,et al.  Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. , 2002, American journal of respiratory and critical care medicine.

[37]  H. Kuo,et al.  Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[38]  G. Hommel,et al.  Interleukin-7 or Interleukin-15 Enhances Survival of Mycobacterium tuberculosis-Infected Mice , 2000, Infection and Immunity.

[39]  Horng-Chyuan Lin,et al.  Nitric Oxide Modulates Interleukin-1 β and Tumor Necrosis Factor- α Synthesis by Alveolar Macrophages in Pulmonary Tuberculosis , 2000 .

[40]  E. Clementi,et al.  Generation of Nitric Oxide by the Inducible Nitric Oxide Synthase Protects γδ T Cells from Mycobacterium tuberculosis-Induced Apoptosis , 1999, The Journal of Immunology.

[41]  N. Juffermans,et al.  Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment , 1999, Clinical and experimental immunology.

[42]  S. Giosué,et al.  Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. , 1999, American journal of respiratory and critical care medicine.

[43]  Maes,et al.  Immunological relatedness of the protective mechanisms against tuberculosis and cancer , 1998, European journal of clinical investigation.

[44]  L. Bermudez,et al.  Interleukin-7 induces anti-Mycobacterium avium activity in human monocyte-derived macrophages. , 1996, The Journal of infectious diseases.

[45]  J. Flynn,et al.  The immunological aspects of latency in tuberculosis. , 2004, Clinical immunology.